This inventor holds 16 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: The General Hospital Corporation, The Netherlands Cancer Institute. Active years: 2001-2026. Education: University of California, Berkeley (USA); Harvard University (USA). Nobel Prize laureate.
Graduated from:
- University of California, Berkeley (USA)
- Harvard University (USA)
Location History:
- Cambridge, MA (US) (2002)
- Newton, MA (US) (2001 - 2024)
Company Filing History:
16 out of 3,068 
1 out of 8 Years Active: 2001-2026
Gary Ruvkun, a 2024 Nobel Prize laureate in Physiology or Medicine, has profoundly shaped our understanding of genetic regulation and aging. As a molecular biologist and professor at Harvard Medical School, Ruvkun’s groundbreaking research on microRNAs, tiny RNA molecules that regulate gene expression, has unveiled a new dimension of biological control mechanisms. His pioneering work with the nematode C. elegans revealed how these small RNAs influence the development and longevity of organisms. This discovery has broad implications for aging, disease, and biotechnology. Alongside his research partner, Victor Ambros, Ruvkun’s contributions have expanded the frontier of molecular biology, revealing insights into RNA interference and its therapeutic potential. His intellectual rigor and relentless curiosity have earned him a place among the most esteemed scientists of our time.